did you read the news today guys ! AWESOME! Easton Pharmaceuticals Receives Final Changes and Nears Completion on Its Reg. A SEC Filing to Raise Up to $5,000,000 in Additional Committed Financing
TORONTO, ON--(Marketwired - Apr 23, 2014) - Easton Pharmaceuticals Inc. (OTC: EAPH) announces it has received a final draft of its Reg. A SEC document that is set to be filed with the Securities and Exchange Commission later this week.
Easton's Delaware attorney has submitted final changes of the filing to the company's board for review and comment. The company anticipates submitting the filing with the Securities and Exchange Commission sometime within the next few days or the end of this week. The Reg. A filing is being supported by its current finance partners who in the past 9 months have advanced Easton Pharmaceuticals with $1,000,000 in financing. Once filed with the SEC, the company should receive comments back, if any, within 10 to 20 days. The company's current financing partners have committed to move forward, have asked for an exclusive and believe they will be able to finance the full $5,000,000 over the next year.
The additional financings are required to fulfill most, if not all initiatives which includes purchasing majority control of its early stage cancer drug "Xilive," completing patent applications and to move towards initiating early stage clinical trials in certain select countries and jurisdictions. Funding is also required to start manufacturing, marketing and sales of its OTC "Viorra" product and its other OTC line of products which are all at different stages of development, as well as to move towards finalizing on its medical marijuana initiatives which have advanced.
Easton Pharmaceuticals believes its efforts in the medical marijuana industry may soon result in a positive development that will allow the company to enter the medical marijuana industry as a possible grower and seller of medical marijuana and other types of marijuana products, which will include future growth and expansion abilities. This may initially involve certain jurisdictions of the United States, Canada and possibly both with adequate financing.
